Ignite Creation Date:
2024-05-06 @ 5:09 PM
Last Modification Date:
2024-10-26 @ 2:23 PM
Study NCT ID:
NCT05218603
Status:
RECRUITING
Last Update Posted:
2022-09-16
First Post:
2022-01-17
Brief Title:
Evaluation of Maintenance With Bortezomib Plus Daratumumab V-Dara After Induction With Bortezomib Melphalan Prednisone Plus Daratumumab VMP-Dara in Newly Diagnosed Multiple Myeloma MM Patients Non-eligible for autoSCT
Sponsor:
PETHEMA Foundation
Organization:
PETHEMA Foundation
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-30
Start Date Type:
ACTUAL
Primary Completion Date:
2025-11-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-11-06
Completion Date Type:
ESTIMATED
First Submit Date:
2022-01-17
First Submit QC Date:
January 28 2022
Study First Post Date:
2022-02-01
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-15
Last Update Post Date:
2022-09-16
Last Update Post Date Type:
ACTUAL